-
Thukukile Zuma Resigns from ANC Johannesburg Leadership Amid Disciplinary Dispute
-
Russia Orders 100,000 Kometa Modules to Counter Ukrainian Electronic Warfare
-
CM Mohan Yadav Meets Bohra Spiritual Leader to Discuss Simhastha 2028 and Development
-
Mahayuti-backed Rajesh Patil Elected Chairman of Gokul Dairy Amidst Political Deadlock
-
Eli Crane Defeats Jonathan Nez in Tight Arizona Congressional Race
-
David Walliams Identified as Celebrity in Sexual Misconduct Allegations After Legal Bid
-
Sherilyn Smith Encourages Women to Embrace Scars as Symbols of Resilience
-
Korea's Severe Asthma Patients Blocked from Biologics by Restrictive Reimbursement Rules
-
Belgium Signs Contract for 20 Rheinmetall Skyranger Air Defence Systems
-
Shanghai Science and Technology Museum Signs Pacts With London and Ottawa Institutions at CIIE
-
NextBoat Inc. to Announce Third Quarter 2026 Financial and Operating Results on Monday, November 16, 2026
-
Shooting Victim Lawyer in Philadelphia David P. Thiruselvam Explains When Property Owners and Businesses Can Face Civil Claims After a Shooting
-
Retired Army Officer Earns Two Degrees While Navigating Family Health Challenges
-
Remergify Opens Waitlist for AI Allowance, a Plain-English Way to Let AI Assistants Shop Within Limits You Set
-
An Investigational Drug to Tackle Measles Outbreaks
-
Ondas Receives Purchase Order for Next-Generation Tactical Attack Drones, Aims to Leverage Planned ARAN Defense Acquisition to Manufacture Thousands of Systems
-
First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
-
Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
-
ACCESS Newswire Reports Third Quarter 2026 Results
-
T4 Robotics Appoints Paul Hughes as Co-CEO and Announces Expansion into Unmanned Maritime Systems
-
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
-
Kalm with Kava and Pū'iwa Farms Hawai'i Bring Fresh Frozen Hawaiian Kava to Market
-
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
-
SMX Advances Development of its Scientific Intelligence, an AI-Powered Platform Intended to Create a Comprehensive Codex for Chemical Agents, Additives and Supplements
-
Jerash Holdings Reports Fiscal 2027 Second Quarter Financial Results
-
Four Nines Gold Intersects 67 Metres at 1.78 g/t Gold, Reinforing Emerging Gold Corridor at Hayden Hill
-
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
-
Your Patients Are Asking AI About You. AimwellBio Lets Every Physician See the Answer, Free.
-
ByNext Joins the Bilt Neighborhood: Reaching More Customers by Integrating Its Technology with Bilt Neighborhood OS
-
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
-
Cardiff Lexington To Report Third Quarter 2026 Financial Results and Host Conference Call on Monday, November 16, 2026
-
Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL
-
Securitas Healthcare Introduces a New Era of RTLS Built for the Future of Healthcare Operations
-
BioTech Breakthrough Acknowledges Champions Oncology Innovation with the "Contract Research and Development Innovation Award"
-
Allstar Health Brands Confirms MLS NEXT Expansion Bid to Anchor a Permanent Training Structure and a Professional Pathway
-
SNZweig Forms AEC Industry Advisory Council
-
Critical Elements' 10,000-Meter Summer Drill Program at Rose West Continues to Deliver Positive Results
-
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 10
-
Fulcrum Metals PLC Announces Fulcrum to Increase Shareholding in Loyalist
-
Spectrocell Strengthens Product Discovery and Customer Engagement with Bioz Badges
-
3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
-
Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
-
KIFFIK Biomedical Recognized as Top Biomarker Access Technology 2026 by Life Sciences Review
-
Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
-
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
-
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
-
Gamma Resources Announces Planned Radon Flux Baseline Survey at Mesa Arc Uranium Project in New Mexico, Provides Update on Project Timelines
-
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
-
Odyssey Behavioral Healthcare Launches Virtual Intensive Outpatient Mental Health Treatment for Adults
RxPR: The First Public Relations and Business Development Agency Dedicated to Pharmacy Launches January 30, 2025
First podcast about the profession of pharmacy builds 70K+ listener market and network to expand client's brands, stories, and connections to pharmacy leaders.
BROWNSVILLE, PENNSYLVANIA / ACCESS Newswire / January 30, 2025 / RxPR, the first public relations and business development agency exclusively dedicated to the pharmacy profession, is officially launching on January 30, 2025. Founded by Todd Eury, a seasoned expert with over 20 years of experience in pharmacy business development, marketing, and social media strategy, RxPR aims to redefine how pharmacists and pharmacy businesses achieve recognition and growth in today's healthcare landscape.
RxPR's mission is clear: to empower pharmacists as leading healthcare providers and elevate the pharmacy profession as a cornerstone of patient care. Combining strategic business development expertise, cutting-edge marketing techniques, and deep insights into public policy, RxPR offers clients unparalleled opportunities for sustainable growth and success.
RxPR, LLC is the parent company which Pharmacy Podcast Network will be a special division serving the pharmacy profession. RxPR has formed special agreements and partnerships with Finch Marketing, Medika Life, Dispense Times Magazine, and Suite Works. Concentrating on building connections between pharmacy buying groups, software technology, trade associations, and other special collaborations, RxPR is prepared to elevate the brands and messaging of it's client's businesses.
A Vision for Pharmacy's Future
RxPR is more than just an agency-it is a movement to spotlight the essential role pharmacists play in modern healthcare. Through innovative campaigns and personalized strategies, RxPR will help clients navigate the complex market dynamics of the pharmacy sector, improve stakeholder engagement, and increase shareholder value.
Key Services Include:
Comprehensive PR and media relations to amplify brand stories.
Strategic business development and scalable growth solutions.
Expert-led marketing campaigns tailored to pharmacy audiences.
In-depth insights into public policy and advocacy strategies.
Dynamic social media content creation and distribution.
Strengthening Pharmacy Through Proven Experience, Networking, and Expertise
With the strength of the Pharmacy Podcast Network - the first and largest podcast network dedicated to pharmacy-RxPR leverages 15 years of digital content creation and distribution expertise. RxPR also collaborates with leading trade and advocacy associations, positioning clients at the forefront of industry innovation.
Todd Eury, founder and CEO of RxPR, shared his vision:
"Pharmacy is at a crossroads. With pharmacy deserts growing and healthcare dynamics shifting, we must amplify the voices of pharmacists and independent pharmacies. RxPR is uniquely positioned to deliver the messaging, strategies, and advocacy needed to help our clients thrive. This isn't just about business-it's about building a stronger healthcare system through pharmacy."
Follow RxPR's Journey
To stay up to date with RxPR's latest projects and insights into the pharmacy industry, follow them on Twitter at @RxPR25
About RxPR
RxPR is the first public relations and business development agency exclusively dedicated to the pharmacy profession. With an innovative approach to PR and marketing, RxPR is committed to advancing the success of pharmacists and pharmacy businesses. Through industry expertise, strategic campaigns, and impactful storytelling, RxPR empowers clients to lead the future of pharmacy.
Contact Information
Todd Eury
CEO
[email protected]
412-585-4001
RxPR.net
SOURCE: RxPR
View the original press release on ACCESS Newswire
D.Kaufman--AMWN